Clinical Evaluation of Bacitracin

• Status: Completed
• Trial end date: 2005-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to establish a concentration of a bacitracin-patch for diagnosing allergic contact dermatitis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mekos Laboratories AS
• Treatments: Bacitracin

Criteria

Inclusion Criteria:

• Positive bacitracin patch test within the latest 5 years.

• Age greater than or equal to 18 years.

• Signed informed consent.

Exclusion Criteria:

• Topical treatment with corticosteroids or immunosuppressives during the latest 7 days on the test area or near the test area.

• Systemic treatment with corticosteroids or immunosuppressives during the latest 7 days.

• Treatment with ultraviolet (UV)-light during the latest 3 weeks.

• Widespread active dermatitis or dermatitis on test area.

• Breast-feeding or pregnancy. Females of childbearing potential must demonstrate a negative pregnancy test before inclusion in the study.

• Subjects not able to cooperate.